Avinger Announces Expanded FDA Indications for Pantheris™ as Diagnostic Imaging Device
19 oct. 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Oct. 19, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that the...
Avinger Signs Agreement with U.S. Department of Veterans Affairs for Lumivascular Technology
13 sept. 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a developer of innovative treatments for peripheral artery disease (PAD), today announced the company has...
Avinger Signs Agreement with HealthTrust for Lumivascular Technology
07 sept. 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a developer of innovative treatments for peripheral artery disease (PAD), today announced it has signed an...
Avinger, Inc. Announces Closing of Public Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional Shares
16 août 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger, Inc. Announces Pricing of Public Offering of Common Stock
11 août 2016 08h30 HE
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger, Inc. Announces Proposed Public Offering of Common Stock
10 août 2016 16h05 HE
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger, Inc. Announces Participation in Canaccord Genuity 36th Annual Growth Conference
09 août 2016 07h30 HE
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the...
Avinger, Inc. Announces Second Quarter 2016 Results
01 août 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger, Inc. to Announce Second Quarter 2016 Results on Monday, August 1, 2016
25 juil. 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., July 25, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
Avinger, Inc. Announces Preliminary Second Quarter 2016 Revenue Results
12 juil. 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., July 12, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that based on...